Asceneuron Appoints Prominent Healthcare Leader Catherine Moukheibir to its Board of Directors

Underscores company's ambition to deliver on the unmet needs of patients living with neurodegenerative diseases LAUSANNE, Switzerland and SAN FRANCISCO, July 16, 2021 /PRNewswire/ -- Asceneuron SA, a clinical stage company dedicated to targeting the root cause of neurodegenerative...

from PR Newswire: https://ift.tt/36GbkKo